Evidence map›Paper›PMID 42082485›Full record

ArticleNature communications2026

Notch is a ligand of Draper mediating spermatogonia cell death.

Heba Abo Romi, Neven Serhan, Lilach Porat-Kuperstein, Hila Toledano

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Heba Abo Romi *The Herta & Paul Amir School of Medicine and the Department of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Neven Serhan *The Herta & Paul Amir School of Medicine and the Department of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Lilach Porat-KupersteinThe Herta & Paul Amir School of Medicine and the Department of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.ORCID http://orcid.org/0000-0003-0404-0336
Hila ToledanoThe Herta & Paul Amir School of Medicine and the Department of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel. hila@univ.haifa.ac.il.ORCID http://orcid.org/0000-0001-9409-7728

Funding

Israel Science Foundation (ISF) 1086/25
6 · The paper itself

Abstract

Notch signalling is traditionally mediated through direct interaction between the Notch receptor and its transmembrane ligands, presented on the surface of adjacent cells. While both canonical and non-canonical pathways activate Notch signalling in signal-receiving cells, it remains unclear whether Notch itself can function as a ligand to activate receptors in neighboring cells. Here, we report that in the Drosophila testis, Notch expressed in spermatogonial progenitors, functions as a ligand for the phagocytic receptor Draper on neighboring somatic cyst cells. This Reverse-Notch signalling triggers spontaneous elimination of germ cell progenitors. We show that Notch binds Draper directly via its extracellular domain, independent of canonical Notch pathway activation. Furthermore, manipulation of Notch signaling is dispensable for this process, indicating a ligand-only role for Notch. These findings redefine Notch as a bifunctional protein capable of acting as both receptor and ligand, expanding the conceptual framework of Notch signalling beyond its conventional unidirectional pathway.

Indexed as

Drosophila ProteinsMembrane ProteinsReceptors, NotchSpermatogoniaAnimalsCell DeathDrosophila melanogasterLigandsMaleSignal TransductionTestisDrosophila ProteinsLigandsMembrane ProteinsN protein, DrosophilaReceptors, Notch

Identifiers

PMID42082485
PMCPMC13346508

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.